Skip to content

Continuous Versus Intermittent Oxytocin Infusion for Induction of Labor

A Comparison Between Continuous Versus Intermittent Oxytocin Infusion for Induction of Labor

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04017247
Enrollment
153
Registered
2019-07-12
Start date
2019-11-01
Completion date
2022-06-30
Last updated
2023-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Induced; Birth

Brief summary

The study will compare 2 treatment modalities. One group will receive the routine protocol of intermittent pitocin induction for 6 hours and the second group will receive continous pitocin infusion for 16 hours. The primary aim is to observe which protocol leads to the fastest delivery and evaluate the time in each group from induction to delivery.

Detailed description

After singing an informed consent, and prior to IOL initiation, study participants were randomly assigned (1:1) to receive either intermittent or continuous Oxytocin infusion. Both groups received the same primary infusion dose of Oxytocin 1.0 with an incremental increase of 2.5 every 30 minutes until 20, titered to a target of 3-5 contractions in a 10 minute period. During Oxytocin infusion, fetal heart rate was continuously monitored. Artificial ROM was performed according to the accepted indications, local protocol and by the staff physician discretion who was in charge on the labor ward at that time, regardless of oxytocin initiation time. In the intermittent Oxytocin infusion group, Oxytocin was discontinued after 8 h if the patient did not go into active labor during by that time, and renewed 4 h later. In the continuous infusion group, patients received a continuous Oxytocin infusion for 16 h. If they did not go into active labor within this frame time, Oxytocin was discontinued for 4 hours and then resumed. In addition, during Oxytocin infusion, sodium levels were monitored every 8 h.

Interventions

DRUGOxytocin

Intermittent oxytocin Infusion

Sponsors

Rambam Health Care Campus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

1. Women with a singleton pregnancy that are admitted for induction or augmentation of labor. 2. Women at gestational age 370/7 or more. 3. Vertex presentation.

Exclusion criteria

1. Age under 18 or over 45. 2. High order gestation. 3. Women with contraindication for vaginal delivery. 4. Active labor. 5. Women with a uterine scar. 6. Multiparity(\> 5 deliveries). 7. Documented fetal anomalies.

Design outcomes

Primary

MeasureTime frameDescription
Delivery within 24 hoursfrom admission up to 24 hours postpartumThe percentage of women delivering within 24 hours.

Secondary

MeasureTime frameDescription
caesarian deliveriesfrom admission up to 24 hours postpartumThe rate of caesarian deliveries.
instrumental deliveriesfrom admission up to 24 hours postpartumThe rate of instrumental deliveries.
latent phase of labor.from admission up to 24 hours postpartumLength of latent phase of labor.
active phase of labor.from admission up to 24 hours postpartumLength of active phase of labor.

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026